US Patent Issued to Gilead Sciences on Dec. 23 for "LPA receptor antagonists and uses thereof" (Canadian, American Inventors)

ALEXANDRIA, Va., Dec. 23 -- United States Patent no. 12,503,454, issued on Dec. 23, was assigned to Gilead Sciences Inc. (Foster City, Calif.).

"LPA receptor antagonists and uses thereof" was invented by Brian P. Bestvater (Vancouver, Canada), Zhimin Du (Belmont, Calif.), Julie Farand (San Mateo, Calif.), Chandrasekar Venkataramani (San Carlos, Calif.) and Kin S. Yang (Foster City, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates generally to compounds that bind to Lysophosphatidic Acid Receptor 1 (LPAR1) and act as antagonists of LPAR1. The disclosure further relates to the use of the compounds for the preparation of a medicament for the treatment of diseases and/or condi...